Help - Search - Members - Calendar
Full Version: Chronic-Obstructive-Pulmonary
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Respiratory > Chronic-Obstructive-Pulmonary
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  1. COPD: Seizures related to severe hypophosphataemia induced by mechanical ventilation (0 replies)
  2. COPD: Associations between underlying disease and nutritional status following acute illness in older people. (0 replies)
  3. COPD: Cd14 is an essential mediator of lps induced airway disease. (0 replies)
  4. COPD: New drive to improve copd care (0 replies)
  5. COPD: Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease (0 replies)
  6. COPD: Bronchial inflammation and airway responses to deep inspiration in asthma and copd. (0 replies)
  7. COPD: Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in spain (0 replies)
  8. COPD: Inhaled short-acting beta-agonist not effective prior to bronchoscopy in patients with copd (0 replies)
  9. COPD: Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of copd patients. (0 replies)
  10. COPD: Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished copd*. (0 replies)
  11. COPD: Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. (0 replies)
  12. COPD: Effect of primary-care spirometry on the diagnosis and management of copd. (0 replies)
  13. COPD: Lancet special issue on copd (0 replies)
  14. COPD: Glaxo's advair fails to hit goal in add-on study (0 replies)
  15. COPD: Copd-call for papers. (0 replies)
  16. COPD: Gsk - advair: clinical trials; ain't they a bitch? (0 replies)
  17. COPD: Inhaled therapy and mortality in copd (0 replies)
  18. COPD: Bronchodilators show no benefit in bronchoscopy patients (0 replies)
  19. COPD: Inhaled steroids may not be as effective in copd treatment (0 replies)
  20. COPD: Inhaled steroids may not be as effective in copd treatment (0 replies)
  21. COPD: Pharmaxis reports phase ii results for aridol in copd (0 replies)
  22. COPD: Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease? (0 replies)
  23. COPD: Copd self-management cost saving versus usual care (0 replies)
  24. COPD: Low concentrations of inhaled nitric oxide do not improve oxygenation in patients with very severe chronic obstructive pulmonary disease (0 replies)
  25. COPD: Directory of ambulatory emergency care for adults (0 replies)
  26. COPD: A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease (0 replies)
  27. COPD: Cigarette smoke exposure inhibits extracellular mmp-2 (gelatinase a) activity in human lung fibroblasts (0 replies)
  28. COPD: Screening of cognitive impairment in chronic obstructive pulmonary disease (0 replies)
  29. COPD: Copd self-management cost saving versus usual care. (0 replies)
  30. COPD: Low bone mineral density in copd patients related to worse lung function, low weight and decreased fat-free mass (0 replies)
  31. COPD: Inhaled therapy in elderly copd patients; time for re-evaluation? (0 replies)
  32. COPD: Tiotropium bromide saves costs in copd in singapore (0 replies)
  33. COPD: Tiotropium bromide saves costs in copd in singapore (0 replies)
  34. COPD: Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to copd or restrictive thoracic diseases (0 replies)
  35. COPD: [original articles] is there a role for therapeutic lobectomy for emphysema? (0 replies)
  36. COPD: [original articles] replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations (0 replies)
  37. COPD: Lung function decline in smokers slowed by higher physical activity level (0 replies)
  38. COPD: Lung function decline in smokers slowed by higher physical activity level (0 replies)
  39. COPD: Thoughts of the day (0 replies)
  40. COPD: Pulmonary embolism an uncommon cause of copd flare (0 replies)
  41. COPD: Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease (0 replies)
  42. COPD: Are we ready for the challenge? (0 replies)
  43. COPD: Review: human alpha-1-proteinase inhibitor for patients with alpha-1-antitrypsin deficiency (0 replies)
  44. COPD: Exercise moderates risk of developing chronic obstructive pulmonary disease in smokers (0 replies)
  45. COPD: American medical association calls low-tar cigarettes a hoax, lobbies for bill to require low-tar cigarettes (0 replies)
  46. COPD: Cells in the lung clear the air to prevent lung damage (0 replies)
  47. COPD: Tiotropium bromide saves costs in copd in singapore. (0 replies)
  48. COPD: Higher physical activity level slows lung function decline in smokers (0 replies)
  49. COPD: Chronic obstructive pulmonary disease: diagnosis and management (0 replies)
  50. COPD: Risk factors for uterine prolapse in nepal (0 replies)
  51. COPD: Exercise slows lung function decline in smokers (0 replies)
  52. COPD: Exercise slows lung function decline in smokers (0 replies)
  53. COPD: Exercise may reduce risk for copd in smokers (0 replies)
  54. COPD: Decrease in ntprobnp plasma levels indicates clinical improvement of acute decompensated heart failure. (0 replies)
  55. COPD: [original articles: cardiovascular] effect of prior valve type on mortality in reoperative valve surgery (0 replies)
  56. COPD: [original articles: cardiovascular] aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts (0 replies)
  57. COPD: New medlineplus magazine issue (0 replies)
  58. COPD: Prevalence and diagnosis of severe pulmonary hypertension in patients with chronic obstructive pulmonary disease (0 replies)
  59. COPD: [editorials] what is (and what is not) a copd exacerbation: thoughts from the new gold guidelines (0 replies)
  60. COPD: [bts guidelines] intermediate care--hospital-at-home in chronic obstructive pulmonary disease: british thoracic society guideline (0 replies)
  61. COPD: [chronic obstructive pulmonary disease] chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? (0 replies)
  62. COPD: [chronic obstructive pulmonary disease] a disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology (0 replies)
  63. COPD: [lung alerts] detecting pe in copd (0 replies)
  64. COPD: Home hospice -vs- nursing home hospice: the difference (0 replies)
  65. COPD: Salmeterol plus fluticasone improves outcomes in copd (0 replies)
  66. COPD: High-risk and low-risk screening for abdominal aortic aneurysm both reduce aneurysm-related mortality. a stratified analysis from a single-centre randomised screening trial. (0 replies)
  67. COPD: Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients? (0 replies)
  68. COPD: The role of combination therapy with corticosteroids and long-acting ss2-agonists in the prevention of exacerbations in copd (0 replies)
  69. COPD: Is there any treatment other than drugs to alleviate dyspnea in copd patients? (0 replies)
  70. COPD: Respiratory disorders during sleep in chronic obstructive pulmonary disease (0 replies)
  71. COPD: Evaluation of pde4 inhibition for copd (0 replies)
  72. COPD: Hyperinflation and its management in copd (0 replies)
  73. COPD: Immediate and early discharge for patients with exacerbations of chronic obstructive pulmonary disease: is there a role in "real life"? (0 replies)
  74. COPD: Pharmacological treatment of chronic obstructive pulmonary disease (0 replies)
  75. COPD: Role of n-acetylcysteine in the management of copd (0 replies)
  76. COPD: Diagnosis of airway obstruction in primary care in the uk: the cadre (copd and asthma diagnostic/management reassessment) programme 1997-2001 (0 replies)
  77. COPD: Creatine supplementation and physical training in patients with copd: a double blind, placebo-controlled study (0 replies)
  78. COPD: Use of accelerometers to characterize physical activity patterns with copd exacerbations (0 replies)
  79. COPD: Randomized placebo controlled assessment of airway inflammation due to racemic albuterol and levalbuterol via exhaled nitric oxide testing (0 replies)
  80. COPD: Comparison of oxygenation in peripheral muscle during submaximal aerobic exercise, in persons with copd and healthy, matched-control persons (0 replies)
  81. COPD: Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease (0 replies)
  82. COPD: Risk factors for symptom onset in pi*z alpha-1 antitrypsin deficiency (0 replies)
  83. COPD: Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial (0 replies)
  84. COPD: Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups (0 replies)
  85. COPD: Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. (0 replies)
  86. COPD: Tiotropium bromide saves costs in copd in singapore. (0 replies)
  87. COPD: Read the winter 2007 nih medlineplus magazine (0 replies)
  88. COPD: Landmark study shows important benefits of seretideâ„¢ treatment for patients with fatal lung disease, copd (0 replies)
  89. COPD: Landmark study shows important benefits of seretideâ„¢ treatment for patients with fatal lung disease, copd (0 replies)
  90. COPD: Advair won't lower copd death risk: study (0 replies)
  91. COPD: Tiotropium plus fluticasone-salmeterol helpful in moderate or severe copd (0 replies)
  92. COPD: Results from landmark study suggest that advair 500/50 provides important benefits for patients with copd (0 replies)
  93. COPD: Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease (0 replies)
  94. COPD: Long-term management -- how is my copd patient doing? (0 replies)
  95. COPD: Torch trial (0 replies)
  96. COPD: Combo treatment works best for copd (0 replies)
  97. COPD: Copd and the workplace. is it really possible to detect early cases? (0 replies)
  98. COPD: Advair won't lower copd death risk: study (0 replies)
  99. COPD: Combo treatment works best for copd (0 replies)
  100. COPD: Inhaled corticosteroids don't seem to reduce mortality in copd (0 replies)
  101. COPD: Drug combo improves copd symptoms but misses mortality endoint (0 replies)
  102. COPD: Drug combo improves copd symptoms but misses mortality endpoint (0 replies)
  103. COPD: Long-term continuous oxygen treatment in chronic obstructive pulmonary disease: proper use, benefits and unresolved issues (0 replies)
  104. COPD: Achieving therapeutic clarity in assisted personal body care: professional challenges in interactions with severely ill copd patients (0 replies)
  105. COPD: Original article: salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease (0 replies)
  106. COPD: Editorial: treating copd -- the torch trial, p values, and the dodo (0 replies)
  107. COPD: Correspondence: treating copd (0 replies)
  108. COPD: Cme: salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease (0 replies)
  109. COPD: 'triple therapy' for copd doesn't reduce exacerbations, may improve other outcomes (0 replies)
  110. COPD: Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. (0 replies)
  111. COPD: Combination inhaler therapy for chronic obstructive pulmonary disease. (0 replies)
  112. COPD: Annals of internal medicine tip sheet for feb. 20, 2007, issue (0 replies)
  113. COPD: "in the beginning" of copd: is evolution important? (0 replies)
  114. COPD: 'success for pharmacy' exhibition and seminars (0 replies)
  115. COPD: Acetylcysteine reduces acute exacerbations of copd (0 replies)
  116. COPD: Updated guidelines on asthma and copd (0 replies)
  117. COPD: Severe chronic obstructive pulmonary disease in a family's everyday life in finland: perceptions of people with chronic obstructive pulmonary disease and their spouses (0 replies)
  118. COPD: Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease (0 replies)
  119. COPD: Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer (0 replies)
  120. COPD: Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study (0 replies)
  121. COPD: Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients (0 replies)
  122. COPD: [research papers] tobacco-related disease mortality among men who switched from cigarettes to spit tobacco (0 replies)
  123. COPD: Acetylcysteine reduces acute exacerbations of copd. (0 replies)
  124. COPD: Levofloxacin may reduce hospitalisations in patients with acute exacerbation of chronic obstructive pulmonary disease (0 replies)
  125. COPD: Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe copd. (0 replies)
  126. COPD: Effect of rollator use on health-related quality of life in individuals with copd. (0 replies)
  127. COPD: Rehabilitation in a warm versus a colder climate in chronic obstructive pulmonary disease: a randomized study. (0 replies)
  128. COPD: Roflumilast for patients with copd (0 replies)
  129. COPD: Ministerial industry strategy group launches long-term leadership strategy for pharmaceutical ... (0 replies)
  130. COPD: Effects of propofol and ketamine on atp-induced contraction of the rat trachea (0 replies)
  131. COPD: [chronic obstructive pulmonary disease] should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? (0 replies)
  132. COPD: [chronic obstructive pulmonary disease] quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease (0 replies)
  133. COPD: [chronic obstructive pulmonary disease] cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in copd (0 replies)
  134. COPD: [editorials] chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism (0 replies)
  135. COPD: [editorials] sarcopaenia in chronic obstructive pulmonary disease (0 replies)
  136. COPD: Advair vs. salmeterol for copd (0 replies)
  137. COPD: The traditional herbal medicine hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease (0 replies)
  138. COPD: Helium-oxygen mix increases exercise capacity in copd (0 replies)
  139. COPD: Helium-oxygen mix increases exercise capacity in copd (0 replies)
  140. COPD: Relation between concentration of air pollution and cause-specific mortality: four-year exposures to nitrogen dioxide and particulate matter pollutants in 470 neighborhoods in oslo, norway (0 replies)
  141. COPD: Patients helped to breathe easier with helium (0 replies)
  142. COPD: Levofloxacin may reduce hospitalisations in patients with acute exacerbation of chronic obstructive pulmonary disease. (0 replies)
  143. COPD: Maximal strength training of the legs in copd: a therapy for mechanical inefficiency. (0 replies)
  144. COPD: Copd: which treatment is right for my patient (0 replies)
  145. COPD: Chronic obstructive pulmonary disease and weaning of difficult-to-wean patients from mechanical ventilation: randomized prospective study. (0 replies)
  146. COPD: The changing face of copd. (0 replies)
  147. COPD: [original articles] mortality from non-malignant respiratory diseases among people with silicosis in hong kong: exposure-response analyses for exposure to silica dust (0 replies)
  148. COPD: A comparison of twice- versus once-weekly supervision during pulmonary rehabilitation in chronic obstructive pulmonary disease. (0 replies)
  149. COPD: Tracheal rupture resulting in life-threatening subcutaneous emphysema. (0 replies)
  150. COPD: A community study of the effect of particulate matter on blood measures of inflammation and thrombosis in an elderly population (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.